Piper Jaffray maintained an Overweight rating and $6.00 price target on CareDx, Inc (NASDAQ: CDNA) following the company's presentation of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Mizuho Securities Cuts Price Target on CareDx (CDNA) to $8 Following Allenex Acquisition June 14, 2016 7:20 AM Unusual 11 Mid-Day Movers 6/13: (EBIO) (LNKD) (PWE) Higher; (MRNS) (GBR) (ARGS) LowerJune 13, 2016 1:01 PM AlloSure™ Shows Promise to Detect Rejection in Transplant Patients with a Simple Blood TestJune 13, 2016 7:30 AM